[Analysis of HIV antibody positivity and influencing factors among new type drug users at AIDS surveillance posts in Zhejiang Province from 2017 to 2023].

Q1 Medicine
Z Yuan, Y Xu, W Cheng, J Z Yang, J Jiang, L Chen, X H Pan
{"title":"[Analysis of HIV antibody positivity and influencing factors among new type drug users at AIDS surveillance posts in Zhejiang Province from 2017 to 2023].","authors":"Z Yuan, Y Xu, W Cheng, J Z Yang, J Jiang, L Chen, X H Pan","doi":"10.3760/cma.j.cn112338-20240924-00593","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To analyze the HIV antibody positivity of new type drug users in drug abuse monitoring sites in Zhejiang Province from 2017 to 2023 and its influencing factors. <b>Methods:</b> From 2017 to 2023, a continuous cross-sectional survey was carried out in HIV monitoring posts among new type drug users in Zhejiang Province,the sample size was 400 people per site of 9 drug abuse surveillance sites in 7 cities. Questionnaires were conducted to investigate their social demographic information, related behavioral information, AIDS awareness, and acceptance of intervention measures, and blood was collected for HIV and syphilis antibody detection, with new type drugs users in the monitoring population as the research object. SPSS 22.0 software was used for statistical analysis. <b>Results:</b> A total of 13 955 new drug users were surveyed, and the number of new drug users was 2 518, 2 292, 2 526, 2 119, 2 161, 1 064 and 1 275 from 2017 to 2023, respectively, the HIV antibody positive rate of new type drugs users was 0.44%, 1.09%, 2.06%, 1.09%, 1.39%, 1.50%, 2.90%, respectively, and the HIV antibody positive standardized rate showed an increasing trend (all <i>P</i><0.001). The results of multivariate logistic regression analysis showed that marital status: unmarried/divorced/widowed (a<i>OR</i>=3.92, 95%<i>CI</i>: 2.46-6.25), provincial household registration (a<i>OR</i>=3.54, 95%<i>CI</i>: 2.34-5.35), high school education or above (a<i>OR</i>=5.42, 95%<i>CI</i>: 3.68-7.98), sexual activity within the last 1 year after drug use (a<i>OR</i>=1.84, 95%<i>CI</i>: 1.19-2.84), and knowledge that the use of new drugs increases the risk of HIV infection (a<i>OR</i>=2.27, 95%<i>CI</i>: 1.17-4.39) were associated with increased HIV antibody favorable rates among new type drugs users. <b>Conclusions:</b> During 2017-2023, the HIV antibody-positive rate of new type drug users in Zhejiang Province showed an upward trend. It is necessary to strengthen the monitoring and intervention of this population.</p>","PeriodicalId":23968,"journal":{"name":"中华流行病学杂志","volume":"46 4","pages":"662-668"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华流行病学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112338-20240924-00593","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To analyze the HIV antibody positivity of new type drug users in drug abuse monitoring sites in Zhejiang Province from 2017 to 2023 and its influencing factors. Methods: From 2017 to 2023, a continuous cross-sectional survey was carried out in HIV monitoring posts among new type drug users in Zhejiang Province,the sample size was 400 people per site of 9 drug abuse surveillance sites in 7 cities. Questionnaires were conducted to investigate their social demographic information, related behavioral information, AIDS awareness, and acceptance of intervention measures, and blood was collected for HIV and syphilis antibody detection, with new type drugs users in the monitoring population as the research object. SPSS 22.0 software was used for statistical analysis. Results: A total of 13 955 new drug users were surveyed, and the number of new drug users was 2 518, 2 292, 2 526, 2 119, 2 161, 1 064 and 1 275 from 2017 to 2023, respectively, the HIV antibody positive rate of new type drugs users was 0.44%, 1.09%, 2.06%, 1.09%, 1.39%, 1.50%, 2.90%, respectively, and the HIV antibody positive standardized rate showed an increasing trend (all P<0.001). The results of multivariate logistic regression analysis showed that marital status: unmarried/divorced/widowed (aOR=3.92, 95%CI: 2.46-6.25), provincial household registration (aOR=3.54, 95%CI: 2.34-5.35), high school education or above (aOR=5.42, 95%CI: 3.68-7.98), sexual activity within the last 1 year after drug use (aOR=1.84, 95%CI: 1.19-2.84), and knowledge that the use of new drugs increases the risk of HIV infection (aOR=2.27, 95%CI: 1.17-4.39) were associated with increased HIV antibody favorable rates among new type drugs users. Conclusions: During 2017-2023, the HIV antibody-positive rate of new type drug users in Zhejiang Province showed an upward trend. It is necessary to strengthen the monitoring and intervention of this population.

2017 - 2023年浙江省艾滋病监测点新型吸毒人员HIV抗体阳性及影响因素分析
目的:分析2017 - 2023年浙江省药物滥用监测点新型吸毒者HIV抗体阳性情况及其影响因素。方法:2017 - 2023年,对浙江省7个城市9个药物滥用监测点的新型吸毒者HIV监测点进行连续横断面调查,样本量为400人/点。以监测人群中新型吸毒者为研究对象,通过问卷调查其社会人口统计信息、相关行为信息、艾滋病知晓率及对干预措施的接受程度,并采血进行HIV和梅毒抗体检测。采用SPSS 22.0软件进行统计分析。结果:2017 - 2023年共调查新增吸毒人员13 955人,新增吸毒人数分别为2 518人、2 292人、2 526人、2 119人、2 161人、1 064人、1 275人,新型吸毒人员HIV抗体阳性率分别为0.44%、1.09%、2.06%、1.09%、1.39%、1.50%、2.90%,且HIV抗体阳性标准化率呈上升趋势(全部POR=3.92, 95%CI: 2.46 ~ 6.25),省级户籍(aOR=3.54, 95%CI:(2.34 ~ 5.35)、高中及以上学历(aOR=5.42, 95%CI: 3.68 ~ 7.98)、吸毒后1年内的性行为(aOR=1.84, 95%CI: 1.19 ~ 2.84)、知道使用新药会增加HIV感染风险(aOR=2.27, 95%CI: 1.17 ~ 4.39)与新型吸毒者HIV抗体阳性率升高相关。结论:2017-2023年,浙江省新型吸毒者HIV抗体阳性率呈上升趋势。有必要加强对这一人群的监测和干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华流行病学杂志
中华流行病学杂志 Medicine-Medicine (all)
CiteScore
5.60
自引率
0.00%
发文量
8981
期刊介绍: Chinese Journal of Epidemiology, established in 1981, is an advanced academic periodical in epidemiology and related disciplines in China, which, according to the principle of integrating theory with practice, mainly reports the major progress in epidemiological research. The columns of the journal include commentary, expert forum, original article, field investigation, disease surveillance, laboratory research, clinical epidemiology, basic theory or method and review, etc.  The journal is included by more than ten major biomedical databases and index systems worldwide, such as been indexed in Scopus, PubMed/MEDLINE, PubMed Central (PMC), Europe PubMed Central, Embase, Chemical Abstract, Chinese Science and Technology Paper and Citation Database (CSTPCD), Chinese core journal essentials overview, Chinese Science Citation Database (CSCD) core database, Chinese Biological Medical Disc (CBMdisc), and Chinese Medical Citation Index (CMCI), etc. It is one of the core academic journals and carefully selected core journals in preventive and basic medicine in China.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信